Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.
about
Melioidosis: epidemiology, pathophysiology, and management.Insights into -Lactamases from Burkholderia Species, Two Phylogenetically Related yet Distinct Resistance DeterminantsManagement of melioidosisSaturation mutagenesis of Asn152 reveals a substrate selectivity switch in P99 cephalosporinaseIdentification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.Functional characterization of OXA-57, a class D beta-lactamase from Burkholderia pseudomallei.Present and future therapeutic strategies for melioidosis and glanders.Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.The tandem repeats enabling reversible switching between the two phases of β-lactamase substrate spectrum.Evolution of Burkholderia pseudomallei in recurrent melioidosis.Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution.Deletion mutations conferring substrate spectrum extension in the class A β-lactamase.Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motionsClinical problem-solving. Beware of first impressions.In vitro activity of BAL30072 against Burkholderia pseudomallei.Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomalleiNitric oxide from IFNγ-primed macrophages modulates the antimicrobial activity of β-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal SalmonellaCombinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.Perturbation of the two-component signal transduction system, BprRS, results in attenuated virulence and motility defects in Burkholderia pseudomallei.Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis.Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.Membrane-Bound PenA β-Lactamase of Burkholderia pseudomalleiThe genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infectionHigh tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognitionMechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.Melioidosis: molecular aspects of pathogenesis.Reclassification of the Specialized Metabolite Producer Pseudomonas mesoacidophila ATCC 31433 as a Member of the Burkholderia cepacia Complex.Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.Comparative genome-wide analysis reveals that Burkholderia contaminans MS14 possesses multiple antimicrobial biosynthesis genes but not major genetic loci required for pathogenesis.Antibiotic resistance in Burkholderia speciesHigh-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species.Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168delNitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei.Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.
P2860
Q24522461-7E00CF47-5E00-4570-A1C4-1925AE9DA4DCQ27678056-504AE417-6438-4EE0-9DFB-6B09B6CA6BEAQ28245689-79D81504-C1FA-40D0-8891-3157F4DDDCADQ33306655-6C4E6615-F1C2-47BF-8A57-DAABD615AAD9Q33709714-98389F0A-601F-4FBA-931B-4F33CE345843Q33721955-0BAAEA41-4468-477B-A013-20DBCA0F6FA6Q33797791-855ABD46-2296-4740-B12A-137435B3969EQ34170246-8AD2ECD0-9B4F-447F-A4EF-C9B90C285577Q34214749-412CC51B-AD01-48D4-BA20-A42739A6CCADQ34277284-09AF1DA8-AA0F-40B1-BE2A-C13146D142AAQ34282016-B267EBF3-177B-4989-B989-C4E6C5A4F788Q34299058-25E104B2-32F7-4C04-B7A9-29E7609B5050Q34533557-20265051-2002-4F6E-91A8-84EE44E02633Q34805507-48DEA423-C598-4ADA-9D1C-EC8549A4BD21Q35072096-C94B4579-554A-46C4-8BBD-ECA469587676Q35086022-4A498E36-FD76-4827-AA18-4B3ACB2E9807Q35224538-72EF540C-9FDA-4F8F-8A31-0D6FAB899CA8Q35236829-A1685266-1293-47BA-8B9E-D1784F6690ABQ35345951-79B7025C-05AF-4279-A411-83A230B6B36DQ36008941-9ABFCF8F-8AC1-4EB2-83B2-61708D6AD543Q36159486-AB8FA3B6-8500-4A0D-825C-C83CED930B44Q36571985-3A3C439C-1BDC-453E-9B1F-86242470183DQ36630989-17103333-6710-42AC-B7E2-CE2A5D27AEBBQ36644825-7E8859D9-0BA4-4CD4-98ED-7EECAFDD24BDQ37033480-27645059-72A5-43C7-8620-8E1C27B8BBC7Q37074494-2EFA0BFD-51B1-4815-9AC0-8FE6ACBB966DQ37255412-29A73A26-2CFD-43F7-8F4B-6042E59B0224Q38066577-BFCD26E1-4E14-4217-A23D-86955F8AF416Q38259874-E7423B75-DEC5-44C6-97C4-5BD9DC89BAE9Q39306286-E4BC0B78-3113-44A4-B969-B5A464178FA7Q39426298-A3A0AF58-7788-4ACD-AE04-222D57FADF3AQ39582866-83319752-227C-4832-AC82-D96CBBF084AAQ40105957-8A5B245E-1D0A-4D07-A4D6-F0D98A74B1FBQ40542863-8BF840E3-C6D8-4473-A7D9-0D6FAD31FDD1Q41440467-DDBF8E37-4AE8-4A60-845F-B568CA1ADC92Q41874947-8BBA5FF6-B5C7-4AA4-8246-31C0EB0CF8A5Q42110602-FA7E4287-80B9-4141-ADCA-88B5C9D094CFQ42198497-8B90063F-3242-45B8-8EDD-55C3070F2285Q44423713-88E593A3-8963-4674-9D84-1677D9F5BDB1Q46286684-E90A8F9B-B8C3-4B95-A788-9DAC71D67F49
P2860
Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Burkholderia pseudomallei clas ...... or clavulanic acid inhibition.
@en
Burkholderia pseudomallei clas ...... or clavulanic acid inhibition.
@nl
type
label
Burkholderia pseudomallei clas ...... or clavulanic acid inhibition.
@en
Burkholderia pseudomallei clas ...... or clavulanic acid inhibition.
@nl
prefLabel
Burkholderia pseudomallei clas ...... or clavulanic acid inhibition.
@en
Burkholderia pseudomallei clas ...... or clavulanic acid inhibition.
@nl
P2093
P2860
P1476
Burkholderia pseudomallei clas ...... or clavulanic acid inhibition.
@en
P2093
Chanwit Tribuddharat
Donald E Woods
Patricia Baker
Richard A Moore
P2860
P304
P356
10.1128/AAC.47.7.2082-2087.2003
P407
P577
2003-07-01T00:00:00Z